These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats. Pearl SM; Maisonneuve IM; Glick SD Neuropharmacology; 1996; 35(12):1779-84. PubMed ID: 9076757 [TBL] [Abstract][Full Text] [Related]
3. Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine. Glick SD; Maisonneuve IM; Pearl SM Brain Res; 1997 Feb; 749(2):340-3. PubMed ID: 9138735 [TBL] [Abstract][Full Text] [Related]
4. The effect of ibogaine on kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6By mice. Sershen H; Hashim A; Lajtha A Brain Res Bull; 1995; 36(6):587-91. PubMed ID: 7757494 [TBL] [Abstract][Full Text] [Related]
5. Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with D-amphetamine. Glick SD; Rossman K; Wang S; Dong N; Keller RW Brain Res; 1993 Nov; 628(1-2):201-8. PubMed ID: 8313148 [TBL] [Abstract][Full Text] [Related]
6. Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum. Harsing LG; Sershen H; Lajtha A J Neural Transm Gen Sect; 1994; 96(3):215-25. PubMed ID: 7826572 [TBL] [Abstract][Full Text] [Related]
7. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Glick SD; Kuehne ME; Raucci J; Wilson TE; Larson D; Keller RW; Carlson JN Brain Res; 1994 Sep; 657(1-2):14-22. PubMed ID: 7820611 [TBL] [Abstract][Full Text] [Related]
8. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157 [TBL] [Abstract][Full Text] [Related]
9. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat. Borg PJ; Taylor DA Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296 [TBL] [Abstract][Full Text] [Related]
10. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. Maisonneuve IM; Keller RW; Glick SD Eur J Pharmacol; 1991 Jun; 199(1):35-42. PubMed ID: 1893925 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine. Szumlinski KK; Maisonneuve IM; Glick SD Eur J Pharmacol; 2000 Jun; 398(2):259-62. PubMed ID: 10854838 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. Schad CA; Justice JB; Holtzman SG J Neurochem; 1996 Dec; 67(6):2292-9. PubMed ID: 8931460 [TBL] [Abstract][Full Text] [Related]
13. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
14. Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum. Sershen H; Hashim A; Lajtha A Pharmacol Biochem Behav; 1996 Apr; 53(4):863-9. PubMed ID: 8801590 [TBL] [Abstract][Full Text] [Related]
15. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats. Sershen H; Harsing LG; Hashim A; Lajtha A Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749 [TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats. Huang NK; Tseng CJ; Wong CS; Tung CS Pharmacol Biochem Behav; 1997 Mar; 56(3):363-71. PubMed ID: 9077570 [TBL] [Abstract][Full Text] [Related]
17. Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization. Reid MS; Fox L; Ho LB; Berger SP Synapse; 2000 Feb; 35(2):129-36. PubMed ID: 10611638 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine. Maisonneuve IM; Glick SD Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676 [TBL] [Abstract][Full Text] [Related]
19. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism. Gray AM; Connick JH Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162 [TBL] [Abstract][Full Text] [Related]
20. Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats. Sershen H; Hashim A; Lajtha A Neurochem Res; 1994 Nov; 19(11):1463-6. PubMed ID: 7898613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]